MolMed now part of AGC Biologics | LinkedIn
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
Press release issued by MolMed S.p.A. upon request of AGC Inc. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART
Small Cap Conference 2013: listed SMEs meet investors at Borsa Italiana
I giapponesi di Agc l'anciano un'Opa su Molmed e il titolo corre in borsa
Molmed, l'Opa giapponese in bilico per golden power - ilGiornale.it
MolMed receives IND clearance by the FDA to conduct a Phase III trial of TK for high-risk leukaemia in the United States
Press release issued by MolMed S.p.A. at the request of AGC Inc. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PA
Il 2019 è l'anno della svolta per MolMed - MilanoFinanza.it
Azioni MolMed: Quotazione, Andamento e Previsioni | Emanuele Perini
Voluntary Tender Offer launched by AGC Inc. on all ordinary shares of MolMed: the Board of Directors approves the Issuer's not
COMUNICATO STAMPA
Will MolMed soon have its first Cell therapy on the Market?
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
Overview of the Italian Primary Markets
L'ok Ue fa volare Molmed (+11%) - MilanoFinanza.it
Aptamer-Based Antibacterial and Antiviral Therapy against Infectious Diseases | Journal of Medicinal Chemistry
1 - [Note: this notice is the English translation of the official version of the 102 notice which will be in Italian language]
MolMed: Contact Details and Business Profile
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer - ScienceDirect
Frontiers | Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
Innovazione, la Borsa corre con plastica e super batteri - Corriere.it
MolMed - YouTube
Sergio Signore (@signore_sergio) / Twitter
Molmed, Opa dei giapponesi di Agc. Per Berlusconi 30 milioni di plusvalenza - Affaritaliani.it
